General Information
Shionogi Influenza 1601T0831-Healthy
A Phase 3, Multicenter, Randomized, Double-blind Study of Single Dose of S-033188 Compared with Placebo or Oseltamivir 75 mg Twice Daily for 5 Days in Otherwise Healthy Patients with Influenza.
| Protocol | 1601T0831 |
|---|---|
| Identifier | Site No: 844 |
| UID | 58b5e176-141b-4be1-83db-e3f60306d3e1 |
| Status | Done - Archived |
| Phase | 3 |
| Category | Influenza / Mixed Age |
| Launch Year | 2017 |
| NCT Number | - |
| Created | 2017-01-10 14:14 |
| Last Updated | 2017-01-10 14:14 |
Description
No description provided.
Comment
PCRS
Target Dates
| Name | Date | Required |
|---|---|---|
| Enrollment Closed | No | |
| Enrollment Open | No | |
| First Patient First Visit | No | |
| Site Initiation Mtg. | 2017-02-17 | No |
| PI Meeting Start | No | |
| PI Meeting End | No | |
| PI Meeting Arrival | No | |
| PI Meeting Departure | No | |
| Closeout Date | 2017-07-07 | No |
| Final PatientVisit | No | |
| PreStudy Selection Visit | No | |
| Target Date 12 | No | |
| Target Date 13 | No | |
| Target Date 14 | No |
Leadership
| Role | Staff | Login | Required |
|---|---|---|---|
| Principal | Martinez, Gilbert | GJMartinez | No |
| Recruiter | - | No | |
| Coordinator | Rocha, Luis | LRocha | No |
| Regulatory | - | No |
Custom Fields
No custom fields.
Sponsor & Organization
| Sponsor | Shionogi |
|---|---|
| Division | Shionogi |
| Team | Shionogi |
| Managing Site | Catalina Research Institute, LLC |
| Organization |
Contacts
| IRB Ref | |
|---|---|
| CRO | PRA (KS) |
| CRO Ref | |
| Correspondence | 0 |
Opportunity
| Probability | 0 |
|---|---|
| Comment | |
| Status Color | Gainsboro |
| Currency | - |
